Results 101 to 110 of about 3,791 (213)

Developing a peripheral blood RNA‐seq based NETseq ensemble classifier: A potential novel tool for non‐invasive detection and treatment response assessment in neuroendocrine tumor patients receiving 177Lu‐DOTATATE PRRT

Journal of neuroendocrinology
Neuroendocrine tumors (NETs) are presented with metastases due to delayed diagnosis. We aimed to identify NET‐related biomarkers from peripheral blood. The development and validation of a multi‐gene NETseq ensemble classifier using peripheral blood RNA ...
M. Padwal, R. Parghane, A. Chakraborty, A. K. Ujaoney, Narasimha Anaganti, Sandip Basu, Bhakti Basu   +6 more
semanticscholar   +1 more source

Biological Sex Influences the Pharmacokinetics and Organ Dosimetry of ¹⁷⁷Lu-DOTATATE: A Systematic Preclinical Evaluation. [PDF]

Pharmaceuticals (Basel)
Kong X, Li P, Wang Z, Cai C, Zhang M, Qu C, Jin C, Zhang H, Dong Y, Lv K, Han F.   +10 more
europepmc   +1 more source

177Hf as a Competitor in the Synthesis of 177Lu-DOTAtate

Journal of Chemistry and Chemical Engineering, 2016
openaire   +1 more source

Evaluation of segmentation accuracy and the improvement of time effectiveness using deep learning-based segmentation in ¹⁷⁷Lu-DOTATATE dosimetry. [PDF]

EJNMMI Phys
Nakaichi T, Shimizu Y, Nakamura S, Shuto Y, Kasai Y, Shishido A, Kunito K, Nakayama H, Takemori M, Kawamura M, Chiba T, Okamoto H, Kashihara T, Igaki H, Ito K.   +14 more
europepmc   +1 more source

Expanding the therapeutic horizon of ¹⁷⁷Lu-DOTATATE: a review of current evidence. [PDF]

Nagoya J Med Sci
Minamimoto R, Kato K, Iwano S, Nishii R, Abe Y, Naganawa S.   +5 more
europepmc   +1 more source

Cumulative Absorbed Dose and Successive Cyclic Reduction in Absorbed Dose Predict Response to ¹⁷⁷Lu-DOTATATE in Neuroendocrine Tumors. [PDF]

J Nucl Med
Macsuka MJ, Driscoll B, Yeung IWT, Publicover J, Metser U, Juergens R, Myrehaug SD, Laidley D, Wong RK, McGowan DR, Vallis KA.   +10 more
europepmc   +1 more source

Predicting subacute hematological toxicity of 177Lu-DOTATATE therapy using healthy organs' uptake on post-treatment quantitative SPECT: A pilot study. [PDF]

Medicine (Baltimore), 2022
Morland D, Triumbari EKA, Hoog C, Sézin G, Dejust S, Cadiot G, Paris P, Papathanassiou D.   +7 more
europepmc   +1 more source

Disseminated Intravascular Coagulation Following ¹⁷⁷Lu-Dotatate Therapy in a Patient With Metastatic Midgut Neuroendocrine Tumour: A Case Report. [PDF]

Cureus
Sharif H, McRae S.
europepmc   +1 more source

Hemorrhagic disseminated intravascular coagulation after 177Lu-Dotatate in metastatic midgut neuroendocrine tumor: A case report. [PDF]

Medicine (Baltimore), 2021
Worbe N, Worbe N, Damian L, Le Cam-Duchez V, Levesque H, Michel P, Quak E.   +6 more
europepmc   +1 more source

Radiation Safety Assessment of 177Lu-DOTATATE Intra-arterial Peptide Receptor Therapy (PRRT). [PDF]

Indian J Nucl Med
Chauhan MKH, Jha AK, Mithun S, Parab RD, Dwivedi P, Puranik AD, Gala KB, Shetye NS, Kulkarni S, Rangarajan V.   +9 more
europepmc   +1 more source